Venous Stents hold huge potential in curing the increasing number of venous diseases. North America to witness the highest growth

Global Venous Stents Market is expected to reach the market valuation of USD 1,886.4 million by 2027 expanding at a considerable CAGR of 9.2% during the forecast period (2021-2027). In the past few years, deep venous stenting has gained increased attention in treating acute or chronic post-thrombotic obstructions or iliac vein compression. Stents for atrial systems have long been used but they were generally not ideal for the venous system. Veins are larger, externally compressed, have lower flow, and are more scarred. New wall stents are entering the market, these usually need to go through vigorous testing before they can be approved.

For a detailed analysis of the market drivers in Venous Stents Market browse through – https://univdatos.com/report/venous-stents-market
Stents for atrial systems have long been used but they were generally not ideal for the venous system. Veins are larger, externally compressed, have lower flow, and are more scarred. New wall stents are entering the market, these usually need to go through vigorous testing before they can be approved. Two stents Venovo by Bard and Vici by Boston Scientific were approved by FDA in 2019. Some of the characteristics and evidence of these venous stents are previewed in the graphs above. Data for the Venovo stent was collected for 3 years on 170 patients and 5 years for the Vici stent, again on 170 patients. Other key players approved around the same time include Zilver Vena by Cook Medical, Abre by Medtronic, Optimed has developed four types of stents, and Blueflow Venous Stent by Plus Medica GmbH.

Before the pandemic, vascular disease treatments could be elective, urgent, and emergent in nature. Elective Procedures performed routinely also included venous stenting. Urgent and emergent cases combined with nonelective arterial disease comprise approximately 30%-50% of vascular surgery practices. The timelines and efficacy of care were disrupted due to the pandemic. Physicians were in the dilemma of bringing patients to the hospital due to the potential Covid-19 exposure. Also, hospital resources should more appropriately be utilized for covid-related-admissions. Even the outpatient vascular services and office-based laboratories were severely affected mostly for elective venous treatments. In a global survey by ng et al., vascular surgeons reported an 86.9% downscale or suspension of services due to the pandemic.
For a detailed analysis of the Application in the Venous Stents Market browse through – https://univdatos.com/report/venous-stents-marketBased on technology, the venous stents market is bifurcated into iliac vein stent technology and wall stent technology. Illiac vein stent technology is expected to grab a substantial market share in 2020 and is expected to grow significantly during the forecast period owing to its growing popularity which can be attributed to its flexibility, MRI compatibility, good radial force, and inexpensive nature.

Based on application, the venous stents market is fragmented into legs, chest, abdomen, and others. The legs segment of the market will grab the major market share in 2020 and is expected to grow at a considerable CAGR in the upcoming years. Key factors that made the leg segment the frontrunner is the increasing prevalence of deep vein thrombosis. An estimated 900,000 people could be affected by DVT in the United States every year. Additionally, about 33% of the people with cured DVT had a recurrence within 10 years.

Request for a Sample of the report browse throughhttps://univdatos.com/get-a-free-sample-form-php/?product_id=6953

Additionally, the report provides detailed initiatives that are being taken in the field of Venous Stents, globally. The report provides a detailed analysis of regions including North America (the U.S, Canada, and Rest of North America), Europe (Germany, France, Spain, Italy, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and the Rest of the World. North America dominated the market in 2020 owing to an increase in awareness among people about venous stents.

Boston Scientific Corporation, Medtronic Plc, Becton, Dickinson and Company, Plus Medica GmbH & Co. KG, Cook Medical, W. L., Optimed Medizinische Instrumente GmBH, and some other emerging companies such as vesper, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”) are some of the prominent players operating in the global venous stents market. Several M&As along with partnerships have been undertaken by these players to make venous stents as cost-effective and as widely available as possible.

Venous Stents Market Segmentation

Market Insight, by Technology

• Iliac Vein Stent Technology
• Wallstent Technology

Market Insight, by Application

• Leg
• Chest
• Abdomen
• Others

Market Insight, by Disease

• Chronic Deep Vein Thrombosis
• Post Thrombotic Syndrome
• Others

Market Insight, by Region

• North America Venous Stents Market
  • United States
  • Canada
  • Rest of North America
• Europe Venous Stents Market
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific Venous Stents Market
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Rest of World Venous Stents Market

Top Company Profiles

• Boston Scientific Corporation
• Medtronic Plc
• Becton, Dickinson and Company
• Plus Medica GmbH & Co. KG
• Cook Medical
• Optimed Medizinische Instrumente GmBH
• Other Emerging Companies